...
机译:将o血浆作为Car-T细胞和其他养型T细胞疗法的媒体补充剂
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesda Maryland;
机译:将o血浆作为Car-T细胞和其他养型T细胞疗法的媒体补充剂
机译:通过成纤维细胞介导的人干扰素α基因治疗与过继化学免疫治疗相结合的方法治疗人肝细胞癌。
机译:维生素B-6补充可以通过降低肿瘤切除后患有肝细胞癌患者的血浆同型半胱氨酸浓度来介导抗氧化能力
机译:适应性T细胞治疗中T细胞活化和扩展的新型可扩展制造平台
机译:T细胞的代谢重编程以优化过继性T细胞疗法
机译:补充维生素B-6可通过降低肿瘤切除术后肝癌患者血浆同型半胱氨酸浓度来介导抗氧化能力
机译:新型培养基配方增强嵌合抗原受体(轿厢)T细胞效力和抗肿瘤细胞函数用于采用免疫疗法